Skip to main content
Caplight Logo









NovaSight

NovaSight

Private
IsraelHealthcare & Life Scienceshttps://nova-sight.com/

Last Round

Series B

Mar 1, 2024

Total Funding Raised

$23M

Company Overview

NovaSight is a therapeutic devices company that develops eye-tracking-based solutions for the diagnosis and treatment of pediatric vision disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Patient Engagement, Telemedicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

amblyopia treatmentlazy eye treatmentdigital therapeuticsDTxeye-tracking technologypediatric vision careFDA cleared devicedichoptic therapyremote patient monitoringmedical AIvision therapyvision diagnosticstelemedicinemyopia control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NovaSight Comparables

Compare NovaSight with similar companies based on industry and business-model similarity.

NovaSight comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Luminopia, Inc.
87%
Hundred Vision
84%
Vivid Vision
83%

NovaSight Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2024
Series AJul 13, 2020

Key People

Founding team and executive leadership

Ran Yam

CEO & Co-founder

Founding Team

NovaSight Investors

Notable investors and investment history

NovaSight investors
InvestorRounds
RimonciSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors increased 264% MoM, reaching 8.4K.

  • May 2, 2025

    Monthly visitors grew 117% MoM, reaching 2.6K.

NovaSight Filings

Explore SEC and related filing metadata, where available.

NovaSight filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NovaSight's valuation, stock price, and market status.

Is NovaSight a public or private company?

NovaSight is a private company.

What is the current stock price of NovaSight?

NovaSight is a private company with no public stock price. No recent secondary market data is available.

How much is NovaSight worth (valuation)?

Valuation information for NovaSight is not publicly available.

Can I buy NovaSight stock?

NovaSight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NovaSight's last funding round?

NovaSight's most recent funding round was Series B on March 1, 2024.

Who are the main investors in NovaSight?

Key investors in NovaSight include Rimonci.

Will NovaSight IPO soon?

No public IPO plans have been announced for NovaSight.

How can I track NovaSight secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NovaSight's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range14
Year Founded2016
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?